Spark Therapeutics, Inc. ONCE Balance Sheet

Spark therapeutics, inc. (ONCE)

Balance Sheet / TTM

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14
Assets
Current assets:
Cash and cash equivalents
207,137	124,109	76,317	95,247	161,557	201,086	127,687	96,748	146,434	36,811	27,495	58,923	90,615	225,026	274,969	293,530	212,159	223,047	234,412	74,566
Marketable securities
182,775	276,730	342,467	358,359	428,919	446,141	459,863	423,419	332,265	178,983	226,199	237,242	216,033	107,185	-	0	-	-	-	-
Trade and other receivables
35,482	59,873	20,468	47,385	13,506	25,239	21,180	7,906	6,000	5,009	5,946	16,780	1,020	1,233	812	16,944	1,251	933	669	244
Inventory, Net
31,853	30,930	30,093	25,637	20,738	12,674	5,560	0	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
10,700	11,374	44,098	40,512	10,492	6,414	6,684	5,093	4,443	5,519	3,713	1,647	1,565	1,830	1,991	1,132	887	1,111	776	2,551
Total current assets
467,947	503,016	513,443	567,140	635,212	691,554	620,974	533,166	489,142	226,323	263,355	314,593	309,235	335,275	277,773	311,607	214,297	225,091	235,857	77,363
Restricted cash
51,500	53,000	53,000	53,000	53,000	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Marketable securities
39,879	54,830	90,168	94,678	27,964	9,552	0	20,035	96,199	22,768	31,700	21,900	51,920	46,839	-	0	-	-	-	-
Property and equipment, net
72,001	66,183	62,711	95,998	87,280	68,698	62,874	61,713	25,364	25,530	23,097	19,794	19,788	19,554	18,393	16,999	14,194	13,490	13,399	12,674
Right of use asset
67,300	68,200	31,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquired in-process research and development
-	-	-	-	-	-	-	-	0	0	14,950	15,490	15,490	15,490	15,490	0	-	-	-	-
Goodwill
1,143	1,190	1,174	1,198	1,214	1,223	1,290	1,254	1,236	1,195	1,119	1,160	2,096	2,096	2,092	0	-	-	-	-
Other assets
3,712	3,836	4,031	2,338	2,732	2,492	2,566	628	723	814	853	924	1,005	1,078	1,178	1,165	417	408	408	408
Total assets
703,500	750,252	755,508	814,352	807,402	773,519	687,704	616,796	612,668	276,632	335,077	373,862	399,536	420,334	314,928	329,772	228,909	238,990	249,665	90,445
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
18,129	11,518	15,128	19,492	18,048	8,785	15,156	14,183	9,561	15,103	14,021	9,928	8,629	6,764	7,218	9,687	6,227	4,015	3,135	2,676
Accrued expenses
41,695	38,225	34,853	34,790	35,092	23,849	13,868	24,697	15,677	14,432	9,097	13,826	9,279	5,922	5,052	6,529	6,085	3,234	2,448	3,163
Long-term Debt, Current Maturities
7,830	7,828	6,325	4,822	3,320	317	315	312	309	306	304	302	274	-	-	0	-	-	-	-
Current portion of deferred rent
0	0	0	1,365	1,051	989	979	969	1,043	1,033	1,140	771	761	751	741	715	723	565	-	0
Contract with Customer, Liability, Current
22,120	22,120	22,120	0	-	-	-	11,969	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of lease liability
8,400	8,400	6,009	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of deferred revenue
-	-	-	-	0	1,841	22,712	-	4,377	6,276	5,168	5,168	5,168	5,168	5,168	5,182	5,578	5,578	5,578	10,014
Current other liabilities
2,158	2,264	2,002	1,885	1,808	1,656	1,609	1,557	-	-	-	0	-	-	-	-	-	-	-	-
Total current liabilities
100,299	90,401	86,437	62,354	59,319	37,437	54,639	53,687	30,969	37,154	29,732	29,997	24,113	18,607	18,181	22,115	18,615	13,394	11,162	15,854
Long-term Debt, Excluding Current Maturities
41,341	42,925	44,507	46,090	47,671	752	832	912	990	1,069	1,146	1,224	1,300	-	-	0	-	-	-	-
Long-term deferred rent
0	0	0	10,885	7,658	7,914	8,093	8,318	10,302	10,250	11,086	7,498	7,496	7,687	7,877	8,084	8,257	8,469	8,651	8,618
Long-term deferred revenue
132,719	132,719	132,719	160,000	105,000	105,000	105,000	0	0	0	2,591	3,865	5,168	6,471	7,760	9,034	10,337	11,640	12,928	10,767
Long-term lease liability
79,400	78,800	37,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax liability
-	-	-	-	-	-	-	-	0	0	965	1,000	1,936	1,936	1,936	0	-	-	-	-
Other liabilities
3,724	3,793	3,860	38,510	37,879	38,676	39,470	40,255	-	-	-	0	-	-	-	-	-	-	-	-
Total liabilities
357,491	348,648	304,480	317,839	257,527	189,779	208,034	103,172	42,263	48,473	45,522	43,586	40,014	34,702	35,755	39,234	37,210	33,503	32,742	35,240
Stockholders’ equity:
Preferred stock, $0.001 par value. Authorized, 5,000,000 shares; no shares issued or outstanding
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Common stock, $0.001 par value. Authorized, 150,000,000 shares; 37,764,213 shares issued and 37,686,301 shares outstanding as of December 31, 2018; 38,940,860 shares issued and 38,519,183 shares outstanding as of September 30, 2019
39	39	39	38	38	38	37	37	36	31	31	30	30	30	27	27	24	24	24	6
Additional paid-in capital
1,162,314	1,149,906	1,133,250	1,091,873	1,078,989	1,065,438	1,040,906	1,026,590	1,015,363	607,530	596,436	583,973	575,640	569,061	434,003	419,791	314,248	311,135	308,234	54,364
Accumulated other comprehensive loss
-1,281	-691	-524	-1,050	-225	-643	-1,055	-5,914	232	651	-1,689	-794	-53	74	-	0	-	-	-	-
Treasury stock, at cost, 20,222 shares as of December 31, 2017 and 73,960 shares as of September 30, 2018
39,878	39,068	37,385	4,661	4,498	4,020	2,982	1,226	1,185	1,023	552	552	552	552	552	552	-	-	-	0
Retained Earnings (Accumulated Deficit)
-775,200	-708,600	-644,352	-589,687	-524,429	-477,073	-557,236	-505,863	-444,041	-379,030	-304,670	-252,380	-215,543	-182,981	-154,305	-128,728	-122,573	-105,672	-91,336	-81,602
Stockholders' Equity Attributable to Parent
346,009	401,604	451,028	496,513	549,875	583,740	479,670	513,624	570,404	228,158	289,554	330,276	359,521	385,631	279,172	290,537	191,699	205,486	216,922	55,205
Total liabilities and stockholders’ equity
703,500	750,252	755,508	814,352	807,402	773,519	687,704	616,796	612,668	276,632	335,077	373,862	399,536	420,334	314,928	329,772	228,909	238,990	249,665	90,445